Emergence of Extensively Drug-Resistant Proteus mirabilis Harboring a Conjugative NDM-1 Plasmid and a Novel Salmonella Genomic Island 1 Variant, SGI1-Z
Author(s) -
Shangshang Qin,
Hui Qi,
Qijing Zhang,
Di Zhao,
Zhenzhen Liu,
Hao Tian,
Lijuan Xu,
Hui Xu,
Mengmeng Zhou,
Xianju Feng,
HongMin Liu
Publication year - 2015
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00292-15
Subject(s) - proteus mirabilis , tigecycline , genomic island , biology , microbiology and biotechnology , tetracycline , plasmid , colistin , salmonella , drug resistance , aztreonam , genetics , virology , staphylococcus aureus , bacteria , antibiotics , antibiotic resistance , dna , imipenem
Acquisition of blaNDM-1 in bacterial species, such as Proteus mirabilis that is intrinsically resistant to tetracycline, tigecycline and colistin, will make clinical treatment extremely difficult. Here, we characterized an NDM-1-producing clinical isolate of P. mirabilis (PM58) that displayed an extensively drug-resistant (XDR) phenotype, susceptible only to aztreonam. Molecular analysis revealed that PM58 harbored both a conjugative NDM-1 plasmid and a novel Salmonella genomic island 1 variant on chromosome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom